MedTrace Logo

Serratus Anterior Block and Erector Spinae Block in Postoperative Analgesia

NCT04579302 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2021-03-09

No results posted yet for this study

Summary

90 patients scheduled for thoracic cancer surgeries, allocated in 3 groups for serratus anterior block and erector spinae block and control group. during anaesthesia:total intraoperative fentanyl required will be recorded. After surgery, all patients will be connected to PCA device containing morphine solution, the amount of morphine consumed during the first 24 hours will be recorded.

Conditions

  • Postoperative Analgesia

Interventions

PROCEDURE

Serratus anterior block (SAB)

Patients will receive a sonar guided serratus anterior plane block with 20 ml of bupivacaine 0.5%

PROCEDURE

Erector spinae block

Patients will receive a sonar-guided erector spinae plane block with 20 ml of bupivacaine 0.5%

DRUG

Saline (as a placebo)

Patients will receive a sham block with 20 ml saline (as a placebo)

DRUG

Bupivacaine

bupivacaine

Sponsors & Collaborators

  • National Cancer Institute, Egypt

    lead OTHER

Principal Investigators

  • Mohamed E Hassan, MS · National Cancer Institute - Vairo University - Egypt

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2021-02-28
Completion
2021-02-28

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04579302 on ClinicalTrials.gov